Pelthos Therapeutics与Castle Creek Biosciences达成合并协议

Pelthos Therapeutics Inc.与Castle Creek Biosciences, Inc.达成合并协议，Castle Creek股东将获得Pelthos普通股及潜在里程碑付款。交易需满足多项条件，包括监管批准及股东同意。